Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 22, 2018
Pharmacy Choice - News - U.S. Pharmaceutical Industry - January 22, 2018

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

1/22/18 - "Crystalline Form of 5-Amino-2,3-Dihydrophthalazine-1,4-Dione Sodium Salt, Pharmaceutical Preparations Containing the Same and Method for the...
"Crystalline Form of 5- Amino-2, 3- Dihydrophthalazine-1, 4- Dione Sodium Salt, Pharmaceutical Preparations Containing the Same and Method for the Production of Said Form" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Martin, Thomas; Breu, Josef; Brysch,
1/22/18 - "Crystalline Forms of (N, N-Diethylcarbamoyl)methyl Methyl (2e)but-2-Ene-1,4-Dioate, Methods of Synthesis and Use" in Patent Application Approval...
"Crystalline Forms of methyl Methyl but-2-Ene-1, 4- Dioate, Methods of Synthesis and Use" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Mao, Chen; Scheuerman, Randall A.; Karaborni, Sami, filed on September 6, 2017, was made available online on January 11
1/22/18 - "Drug Delivery Device with Live Button Or User Interface Field" in Patent Application Approval Process (USPTO 20170368260)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors McCullough, Adam B.; Gibson, Scott R., filed on December 10, 2015, was made available online on January 11, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Amgen I
1/22/18 - "Intranasal Formulation of Epinephrine for the Treatment of Anaphylaxis" in Patent Application Approval Process (USPTO 20170368000)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor Fleming, Nigel Ten, filed on September 7, 2017, was made available online on January 11, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to G2B Pharma Inc.. About 3 mi
1/22/18 - "Methods for Determining Total Body Skeletal Muscle Mass" in Patent Application Approval Process (USPTO 20170367648)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors HELLERSTEIN, Marc K.; EVANS, William J., filed on July 10, 2017, was made available online on January 11, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to GlaxoSmit
1/22/18 - "Methods of Treating Pulmonary Sarcoidosis" in Patent Application Approval Process (USPTO 20170368150)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor Burns, Barry, filed on September 4, 2015, was made available online on January 11, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Gotham Biopharmaceuticals Inc..
1/22/18 - "Mutated Factor X Polypeptides and Uses Thereof for the Treatment of Haemophilia" in Patent Application Approval Process (USPTO 20170369861)
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventors CHRISTOPHE, Olivier; LENTING, Petrus; DENIS, Cecile, filed on January 6, 2016, was made available online on January 11, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not be
1/22/18 - "N-Benzoate Group Substituted Benzopyrroline-2-One Derivative and Use Thereof" in Patent Application Approval Process (USPTO 20170368028)
By a News Reporter-Staff News Editor at Diabetes Week A patent application by the inventors Xue, Hai; Zhao, Tao; Cha, Mi Young; Kim, Maengsup, filed on January 22, 2016, was made available online on January 11, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Bei
1/22/18 - "Pharmaceutical Compositions and Device Methods for Treatment of Proliferative Diseases" in Patent Application Approval Process (USPTO 20170368235)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor Dinh, Thomas Q., filed on September 4, 2017, was made available online on January 11, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institu
1/22/18 - "Use of Levocetirizine and Montelukast in the Treatment of Anaphylaxis" in Patent Application Approval Process (USPTO 20170368059)
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventor May, Bruce Chandler, filed on July 13, 2017, was made available online on January 11, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institu
1/22/18 - 477 pain pills for every person. Lawsuit charges drug maker flooded Kentucky. [Lexington Herald-Leader]
Jan. 22 A drug wholesaler flooded Kentucky counties with millions of prescription painkillers even as overdose deaths were on the rise, state Attorney General Andy Beshear charged in a lawsuit filed Monday in Franklin Circuit Court. For instance, the company, McKesson Corporation, distributed 18.4 million doses of painkillers called opioids in Fl
1/22/18 - Abaxis, Inc. Announces USDA Approval of New VetScan FLEX4 Rapid Test
Abaxis, Inc., a global diagnostics company manufacturing point-of-care instruments and consumables for the medical and veterinary markets worldwide, today announced that the USDA, Center for Veterinary Biologics, approved its new VetScan FLEX4 Rapid Test for veterinary use. Abaxis plans to begin shipping FLEX4 Rapid Tests to its distributor netwo
1/22/18 - Abbott Laboratories Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Jan. 5, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on January 5, 2018. The SEC file number is 0001179110-18-000645.. A U.S. Securities and Exchange Commission filing is
1/22/18 - Abbott Laboratories Files SEC Form 4/A, Statement of Changes in Beneficial Ownership of Securities: (Jan. 5, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on January 5, 2018. The SEC file number is 0001179110-18-000644.. A U.S. Securities and Exchange Commission filing is
1/22/18 - AbbVie's Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis
By a News Reporter-Staff News Editor at Biotech Business Week AbbVie, a global research and development-based biopharmaceutical company, announced the U.S. Food and Drug Administration granted Breakthrough Therapy Designation for the investigational, once-daily oral JAK1-selective inhibitor upadacitinib in adult patients with moderate to severe..
1/22/18 - Acerus Enters into a Licensing Agreement with Innovus to Commercialize UriVarx in Canada
By a News Reporter-Staff News Editor at Pharma Business Week Acerus Pharmaceuticals Corporation announced that it has entered into an exclusive distributor and license agreement with Innovus Pharmaceuticals, Inc., a California- based specialty pharmaceutical company developing safe and effective over-the-counter medicines, granting Acerus the...
1/22/18 - Active Pharmaceutical Ingredients Market - Global Industry Growth, Trends and Forecast 2015 - 2023
The frontrunners in theglobal active pharmaceutical ingredients (API) marketin 2015, according to a study by Transparency Market Research (TMR), were North China Pharmaceutical Group Corp. (NCPC), Zhejiang Medicine Co. ...
1/22/18 - ADAMAS PHARMACEUTICALS INC FILES (8-K) Disclosing Results of Operations and Financial Condition, Other Events
On January 22, 2018, we expect to file with the Securities and Exchange Commission a Prospectus Supplement in which we will disclose that we had approximately $176.4 million in cash, cash equivalents and investments at December 31, 2017. On January 22, 2018, we provided an update to our risk factors, as last disclosed in our Quarterly Report on For
1/22/18 - Aerie Pharmaceuticals Inc. Files SEC Form 8-K, Current Report: (Jan. 8, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aerie Pharmaceuticals Inc. was posted on January 8, 2018. The SEC file number is 0001193125-18-004998.. A U.S. Securities and Exchange Commission fil
1/22/18 - AIT Therapeutics Announces Further Data From Its NO-NTM Abscessus Phase 2 Clinical Trial in Nontuberculous Mycobacteria (NTM) Patients
AIT Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide for the treatment of patients with serious lung infections and pulmonary hypertension, today announced positive data at Day 81, the end of its NO-NTM Abscessus clinical trial. The Company previously announced positive preliminary data...
1/22/18 - Albert Einstein College of Medicine Details Findings in Clinical Trials and Studies (Minimally Invasive Separation Surgery with Intraoperative...
Albert Einstein College of Medicine Details Findings in Clinical Trials and Studies. According to news reporting out of Bronx, New York, by NewsRx editors, research stated, "The treatment of spinal metastasis consists of algorithms combining surgical and radiation modalities. Our news journalists obtained a quote from the research from the Albert E
1/22/18 - Alcyon Health LLC Showcases Reproductive Health Supplements At January ECRM EPPS Event
Nutraceutical company Alcyon Health LLC attended January's ECRM EPPS event in Washington, D.C., showcasing three of its research-based reproductive health dietary supplements to some of the biggest retail buyers in the U.S.. Alcyon was founded in 2016 when healthcare and marketing professionals Bryan Vantell and Abbas Jamali identified a need fo
1/22/18 - Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) Files An 8-K Entry into a Material Definitive Agreement
Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) Files An 8-K Entry into a Material Definitive AgreementItem 1.01 Entry into a Material Definitive Agreement. On January12, 2018 (the Commencement Date), in connection with the closing of the initial purchase by certain institutional and other accredited investors affiliated with or managed by Redmi
1/22/18 - Allergan Plc Files SEC Form 8-K, Current Report: (Jan. 8, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Allergan Plc was posted on January 8, 2018. The SEC file number is 0001193125-18-006041.. A U.S. Securities and Exchange Commission filing is a forma
1/22/18 - Amag Pharmaceuticals Inc. Files SEC Form 8-K, Current Report: (Jan. 8, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amag Pharmaceuticals Inc. was posted on January 8, 2018. The SEC file number is 0000792977-18-000002.. A U.S. Securities and Exchange Commission fili
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415